Status:
WITHDRAWN
Comparison of Decolonization of Methicillin-resistant Staphylococcus Aureus (MRSA) Using Theraworx
Lead Sponsor:
Mercy Research
Conditions:
Methicillin-Resistant Staphylococcus Aureus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to examine treatment method of Methicillin-resistant Staphylococcus aureus (MRSA) decolonization in patients.
Detailed Description
Decolonization therapy is indicated for management of patients with MRSA. Theraworx is reported to be an effective antimicrobial against multiple organisms. In this study, patients with positive MRSA ...
Eligibility Criteria
Inclusion
- Positive MRSA culture
Exclusion
- Patients currently on or start antibiotic therapy directed for MRSA.(Prophylaxis antibiotic for surgical procedure not considered therapy.)
- Patients with MRSA infected wounds
- Patients under the age of 18 years
- A woman currently pregnant or nursing a child
- Patients participating in another study within 30 days of randomization
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00713674
Start Date
March 1 2008
End Date
February 1 2009
Last Update
March 23 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.